188 related articles for article (PubMed ID: 13948615)
1. [Effects on the female fetus of prolonged treatment with 6-alpha-methyl-17-alpha-hydroxyprogesterone acetate (MAP) during pregnancy].
GOISIS M; CAVALLI P
Minerva Ginecol; 1962 Sep; 14():908-19. PubMed ID: 13948615
[No Abstract] [Full Text] [Related]
2. [On the treatment of threatened abortion with a compound with a 6-alpha-methyl-17-alpha-hydroxyprogesterone acetate (Farlutal) base].
GOISIS M; CAVALLI P; CANDOTTI G
Minerva Ginecol; 1961 Sep; 13():903-5. PubMed ID: 13899588
[No Abstract] [Full Text] [Related]
3. The effect on the female foetus of prolonged treatment with 6-alpha-methyl-17-alpha-hydroxyprogesterone acetate (MAP) during pregnancy.
GOISIS M; CAVALLI P
Panminerva Med; 1963; 5():107-9. PubMed ID: 13948617
[No Abstract] [Full Text] [Related]
4. [Effects of 17-alpha-hydroxyprogesterone caproate in 100 cases of threatened abortion].
CASTELAZO AYALA L; ESPINOSA DE LOS REYES V; GONZALEZ RAMOS M; REYES CEJA L
Ginecol Obstet Mex; 1959; 14():249-61. PubMed ID: 13808265
[No Abstract] [Full Text] [Related]
5. [THE USE OF 6-ALPHA-METHYL-17-ALPHA-ACETOXYPROGESTERONE (M.A.P.) IN OBSTETRICS IN ITS REPERCUSSIONS ON FETUSES OF THE FEMALE SEX].
DESTRO F; PAOLINA L
Minerva Ginecol; 1964 Jun; 16():520-5. PubMed ID: 14190021
[No Abstract] [Full Text] [Related]
6. Maintenance of pregnancy in castrated rabbits by an orally active progestational agent: 6 alpha-methyl 17 alpha-hydroxyprogesterone acetate.
WU DH
Fertil Steril; 1961; 12():236-44. PubMed ID: 13786856
[No Abstract] [Full Text] [Related]
7. [Progesterone and 6-methyl-17-hydroxyprogesterone acetate in the treatment of threatened premature labor].
CIULLA U
Ann Ostet Ginecol; 1960 May; 82():537-45. PubMed ID: 13810388
[No Abstract] [Full Text] [Related]
8. EXPERIENCE WITH MEDROXY-PROGESTERONE ACETATE IN THE CONTROL OF THREATENED LATE ABORTION AND PREMATURE LABOUR.
Wurm R
Aust N Z J Obstet Gynaecol; 1963 Dec; 3(4):145-54. PubMed ID: 14102740
[No Abstract] [Full Text] [Related]
9. The use of intramuscular progesterone in pregnancy with special reference to vaginal aplasia.
FOLEY JJ
J Obstet Gynaecol Br Emp; 1963 Jun; 70():429-36. PubMed ID: 13945760
[No Abstract] [Full Text] [Related]
10. Fetal survival following threatened abortion.
THOMPSON JF; LEIN JN
Obstet Gynecol; 1961 Jul; 18():40-3. PubMed ID: 13776585
[No Abstract] [Full Text] [Related]
11. PROGESTERONE AND 6-METHYL-17-ACETOXYPROGESTERONE IN THREATENED ABORTION AND PREMATURE LABOUR.
FUCHS F
Minerva Ginecol; 1965 Jan; 17():SUPPL:67-70. PubMed ID: 14304426
[No Abstract] [Full Text] [Related]
12. ABORTIONS AND MISCARRIAGES.
WINTERTON WR
Practitioner; 1964 Feb; 192():222-8. PubMed ID: 14122916
[No Abstract] [Full Text] [Related]
13. The relationship of threatened abortion to fetal abnormalities.
BURGE ES
Am J Obstet Gynecol; 1951 Mar; 61(3):615-21. PubMed ID: 14810810
[No Abstract] [Full Text] [Related]
14. [TREATMENT OF THREATENED AND HABITUAL ABORTION WITH MEDROXYPROGESTERONE].
BERARD MJ
Can Med Assoc J; 1964 Aug; 91(5):212-8. PubMed ID: 14178406
[TBL] [Abstract][Full Text] [Related]
15. ON THREATENED ABORTION.
HANSEN H; NILSSON L; ZETTERGREN L
Acta Obstet Gynecol Scand; 1963; 42():117-29. PubMed ID: 14057530
[No Abstract] [Full Text] [Related]
16. [NEW VIEWPOINTS IN ABORTION PREVENTION].
HOHENSEE F
Ther Ggw; 1963 Dec; 102():1479-88. PubMed ID: 14112743
[No Abstract] [Full Text] [Related]
17. TREATMENT OF THREATENED ABORTION WITH PROGESTERONE.
Nilsson L
Acta Obstet Gynecol Scand; 1964; 42(S6):128-35. PubMed ID: 14151817
[No Abstract] [Full Text] [Related]
18. [The us eof intravenous progesterone in threatened abortion].
JASSIN A; JULIAA JJ; GUPITO M
Dia Med; 1962 Sep; 34():1816-7. PubMed ID: 13957539
[No Abstract] [Full Text] [Related]
19. [Use of vitamin E and progesterone in threatened abortion].
PLASTUNOV AB
Vopr Okhr Materin Det; 1962 Dec; 7():56-60. PubMed ID: 13943963
[No Abstract] [Full Text] [Related]
20. THE EFFECT OF TREATMENT OF ABORTION-PRONE WOMEN WITH SECROSTERON AND PROVERA.
Krieger VI
Aust N Z J Obstet Gynaecol; 1963 Sep; 3(3):129-31. PubMed ID: 14065030
[No Abstract] [Full Text] [Related]
[Next] [New Search]
